United States Molecular Diagnostics in Cancer Testing Industry 2016 Market Research Report

Publisher Name :
Date: 06-Oct-2016
No. of pages: 138
Inquire Before Buying

The United States Molecular Diagnostics in Cancer Testing Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Molecular Diagnostics in Cancer Testing industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Molecular Diagnostics in Cancer Testing market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Molecular Diagnostics in Cancer Testing industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 143 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

United States Molecular Diagnostics in Cancer Testing Industry 2016 Market Research Report

Table of Contents
1 Industry Overview
1.1 Definition and Specifications of Molecular Diagnostics in Cancer Testing
1.2 Classification of Molecular Diagnostics in Cancer Testing
1.3 Applications of Molecular Diagnostics in Cancer Testing
1.4 Industry Chain Structure of Molecular Diagnostics in Cancer Testing
1.5 Industry Overview of Molecular Diagnostics in Cancer Testing
1.6 Industry Policy Analysis of Molecular Diagnostics in Cancer Testing
1.7 Industry News Analysis of Molecular Diagnostics in Cancer Testing
2 Manufacturing Cost Structure Analysis of Molecular Diagnostics in Cancer Testing
2.1 Bill of Materials (BOM) of Molecular Diagnostics in Cancer Testing
2.2 BOM Price Analysis of Molecular Diagnostics in Cancer Testing
2.3 Labor Cost Analysis of Molecular Diagnostics in Cancer Testing
2.4 Depreciation Cost Analysis of Molecular Diagnostics in Cancer Testing
2.5 Manufacturing Cost Structure Analysis of Molecular Diagnostics in Cancer Testing
2.6 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
2.7 United States Price, Cost and Gross of Molecular Diagnostics in Cancer Testing 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Molecular Diagnostics in Cancer Testing Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
4 Production Analysis of Molecular Diagnostics in Cancer Testing by Regions, Type, and Applications
4.1 United States Production of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
4.2 United States Production of Molecular Diagnostics in Cancer Testing by Type 2011-2016
4.3 United States Sales of Molecular Diagnostics in Cancer Testing by Applications 2011-2016
4.4 Price Analysis of United States Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Molecular Diagnostics in Cancer Testing 2011-2016
5 Consumption Volume and Consumption Value Analysis of Molecular Diagnostics in Cancer Testing by Regions
5.1 United States Consumption Volume of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
5.2 United States Consumption Value of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
5.3 United States Consumption Price Analysis of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
6 Analysis of Molecular Diagnostics in Cancer Testing Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Molecular Diagnostics in Cancer Testing 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Molecular Diagnostics in Cancer Testing 2014-2015
6.3 Sales Overview of Molecular Diagnostics in Cancer Testing 2011-2016
6.4 Supply, Consumption and Gap of Molecular Diagnostics in Cancer Testing 2011-2016
6.5 Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Cancer Testing 2011-2016
7 Analysis of Molecular Diagnostics in Cancer Testing Industry Key Manufacturers
7.1 Abbott Molecular Diagnostics
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott Molecular Diagnostics SWOT Analysis
7.2 Accugenomics, Inc.
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Accugenomics, Inc. SWOT Analysis
7.3 Agendia
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Agendia SWOT Analysis
7.4 Ambry Genetics
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Ambry Genetics SWOT Analysis
7.5 Biodesix
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Biodesix SWOT Analysis
7.6 bioMerieux
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 bioMerieux SWOT Analysis
7.7 bioTheranostics (AviaraDx)
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 bioTheranostics (AviaraDx) SWOT Analysis
7.8 Cancer Genetics, Inc.
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Cancer Genetics, Inc. SWOT Analysis
7.9 Clarient, Inc. (GE Healthcare)
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Clarient, Inc. (GE Healthcare) SWOT Analysis
7.10 Counsyl
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Counsyl SWOT Analysis
7.11 Flatiron Health
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Flatiron Health SWOT Analysis
7.12 Epigenomics
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Epigenomics SWOT Analysis
7.13 Exact Sciences Corporation
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Exact Sciences Corporation SWOT Analysis
7.14 Exiqon
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Exiqon SWOT Analysis
7.15 Genomic Health, Inc.
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Genomic Health, Inc. SWOT Analysis
7.16 Genoptix, Inc. (Novartis)
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Genoptix, Inc. (Novartis) SWOT Analysis
7.17 Genmark Diagnostics
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Genmark Diagnostics SWOT Analysis
7.18 Genomictree
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Genomictree SWOT Analysis
7.19 HTG Molecular Diagnostics
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 HTG Molecular Diagnostics SWOT Analysis
7.20 Invitae
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Invitae SWOT Analysis
7.21 LabCorp
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 LabCorp SWOT Analysis
7.22 Myriad Genetics, Inc.
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Myriad Genetics, Inc. SWOT Analysis
7.23 Nanostring
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Nanostring SWOT Analysis
7.24 Neogenomics
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Neogenomics SWOT Analysis
7.25 NSTG
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 NSTG SWOT Analysis
7.26 Nuvera Biosciences
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Nuvera Biosciences SWOT Analysis
7.27 Orion Genomics
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Orion Genomics SWOT Analysis
7.28 Pathway Genomics
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Pathway Genomics SWOT Analysis
7.29 Personal Genome Diagnostics
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Personal Genome Diagnostics SWOT Analysis
7.30 Quest Diagnostics
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Quest Diagnostics SWOT Analysis
7.31 Rosetta Genomics Ltd.
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Rosetta Genomics Ltd. SWOT Analysis
7.32 Signal Genetics
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Signal Genetics SWOT Analysis
7.33 Source MDx
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Source MDx SWOT Analysis
7.34 Wilex, Inc.
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 Wilex, Inc. SWOT Analysis
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Molecular Diagnostics in Cancer Testing Product Types
8.5 Market Share Analysis of Different Molecular Diagnostics in Cancer Testing Price Levels
8.6 Gross Margin Analysis of Different Molecular Diagnostics in Cancer Testing Applications
9 Marketing Trader or Distributor Analysis of Molecular Diagnostics in Cancer Testing
9.1 Marketing Channels Status of Molecular Diagnostics in Cancer Testing
9.2 Traders or Distributors of Molecular Diagnostics in Cancer Testing with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Molecular Diagnostics in Cancer Testing
9.4 United States Import, Export and Trade Analysis of Molecular Diagnostics in Cancer Testing
10 Development Trend of Molecular Diagnostics in Cancer Testing Industry 2016-2021
10.1 Capacity and Production Overview of Molecular Diagnostics in Cancer Testing 2016-2021
10.2 Production Market Share by Product Types of Molecular Diagnostics in Cancer Testing 2016-2021
10.3 Sales and Sales Revenue Overview of Molecular Diagnostics in Cancer Testing 2016-2021
10.4 United States Sales of Molecular Diagnostics in Cancer Testing by Applications 2016-2021
10.5 Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Cancer Testing 2016-2021
11 Industry Chain Suppliers of Molecular Diagnostics in Cancer Testing with Contact Information
11.1 Major Raw Materials Suppliers of Molecular Diagnostics in Cancer Testing with Contact Information
11.2 Manufacturing Equipment Suppliers of Molecular Diagnostics in Cancer Testing with Contact Information
11.3 Major Players of Molecular Diagnostics in Cancer Testing with Contact Information
11.4 Key Consumers of Molecular Diagnostics in Cancer Testing with Contact Information
11.5 Supply Chain Relationship Analysis of Molecular Diagnostics in Cancer Testing
12 New Project Investment Feasibility Analysis of Molecular Diagnostics in Cancer Testing
12.1 New Project SWOT Analysis of Molecular Diagnostics in Cancer Testing
12.2 New Project Investment Feasibility Analysis of Molecular Diagnostics in Cancer Testing
13 Conclusion of the United States Molecular Diagnostics in Cancer Testing Industry 2016 Market Research Report
List of Tables and Figures
Figure Picture of Molecular Diagnostics in Cancer Testing
Table Product Specifications of Molecular Diagnostics in Cancer Testing
Table Classification of Molecular Diagnostics in Cancer Testing
Figure United States Sales Market Share of Molecular Diagnostics in Cancer Testing by Product Types in 2015
Table Applications of Molecular Diagnostics in Cancer Testing
Figure United States Sales Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2015
Figure Industry Chain Structure of Molecular Diagnostics in Cancer Testing
Table United States Industry Overview of Molecular Diagnostics in Cancer Testing
Table Industry Policy of Molecular Diagnostics in Cancer Testing
Table Industry News List of Molecular Diagnostics in Cancer Testing
Table Bill of Materials (BOM) of Molecular Diagnostics in Cancer Testing
Table Bill of Materials (BOM) Price of Molecular Diagnostics in Cancer Testing
Table Labor Cost of Molecular Diagnostics in Cancer Testing
Table Depreciation Cost of Molecular Diagnostics in Cancer Testing
Table Manufacturing Cost Structure Analysis of Molecular Diagnostics in Cancer Testing in 2015
Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
Table United States Price Analysis of Molecular Diagnostics in Cancer Testing 2011-2016 (USD/Unit)
Table United States Cost Analysis of Molecular Diagnostics in Cancer Testing 2011-2016 (USD/Unit)
Table United States Gross Analysis of Molecular Diagnostics in Cancer Testing 2011-2016
Table Capacity (K Units) and Commercial Production Date of United States Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Table R&D Status and Technology Source of United States Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table United States Production of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (K Units)
Table United States Production Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure United States Production Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure United States Production Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table United States Production of Molecular Diagnostics in Cancer Testing by Types in 2011-2016 (K Units)
Table United States Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2011-2016
Figure United States Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2014
Figure United States Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015
Table United States Sales of Molecular Diagnostics in Cancer Testing by Applications 2011-2016 (K Units)
Table United States Production Market Share of Molecular Diagnostics in Cancer Testing by Applications 2011-2016
Figure United States Production Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2014
Figure United States Production Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2015
Table Price Comparison of United States Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Molecular Diagnostics in Cancer Testing 2011-2016
Table United States Consumption Volume of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (K Units)
Table United States Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure United States Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure United States Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table United States Consumption Value of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure United States Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure United States Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table Consumption Price of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table United States Capacity Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table United States Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table United States Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Molecular Diagnostics in Cancer Testing 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure United States Capacity Utilization Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure United States Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2014
Figure United States Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Figure United States Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2014
Figure United States Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Figure United States Sales (K Units) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Table United States Supply, Consumption and Gap of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table United States Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table Price of United States Molecular Diagnostics in Cancer Testing Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Molecular Diagnostics in Cancer Testing Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Molecular Diagnostics in Cancer Testing 2011-2016 (M USD)
Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Molecular Diagnostics in Cancer Testing 2011-2016
Table Abbott Molecular Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Abbott Molecular Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Abbott Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Abbott Molecular Diagnostics 2011-2016
Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Accugenomics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Accugenomics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Accugenomics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Accugenomics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Accugenomics, Inc. 2011-2016
Table Accugenomics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Agendia Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Agendia
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Agendia 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Agendia 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Agendia 2011-2016
Table Agendia Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Ambry Genetics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Ambry Genetics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ambry Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Ambry Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Ambry Genetics 2011-2016
Table Ambry Genetics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Biodesix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Biodesix
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biodesix 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Biodesix 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Biodesix 2011-2016
Table Biodesix Molecular Diagnostics in Cancer Testing SWOT Analysis
Table bioMerieux Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of bioMerieux
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of bioMerieux 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of bioMerieux 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of bioMerieux 2011-2016
Table bioMerieux Molecular Diagnostics in Cancer Testing SWOT Analysis
Table bioTheranostics (AviaraDx) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of bioTheranostics (AviaraDx)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of bioTheranostics (AviaraDx) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of bioTheranostics (AviaraDx) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of bioTheranostics (AviaraDx) 2011-2016
Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Cancer Genetics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Cancer Genetics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cancer Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Cancer Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Cancer Genetics, Inc. 2011-2016
Table Cancer Genetics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Clarient, Inc. (GE Healthcare) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Clarient, Inc. (GE Healthcare)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Clarient, Inc. (GE Healthcare) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Clarient, Inc. (GE Healthcare) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Clarient, Inc. (GE Healthcare) 2011-2016
Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Counsyl Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Counsyl
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Counsyl 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Counsyl 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Counsyl 2011-2016
Table Counsyl Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Flatiron Health Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Flatiron Health
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Flatiron Health 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Flatiron Health 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Flatiron Health 2011-2016
Table Flatiron Health Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Epigenomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Epigenomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Epigenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Epigenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Epigenomics 2011-2016
Table Epigenomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Exact Sciences Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Exact Sciences Corporation
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exact Sciences Corporation 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Exact Sciences Corporation 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Exact Sciences Corporation 2011-2016
Table Exact Sciences Corporation Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Exiqon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Exiqon
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exiqon 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Exiqon 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Exiqon 2011-2016
Table Exiqon Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genomic Health, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genomic Health, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomic Health, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomic Health, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Genomic Health, Inc. 2011-2016
Table Genomic Health, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genoptix, Inc. (Novartis) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genoptix, Inc. (Novartis)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genoptix, Inc. (Novartis) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genoptix, Inc. (Novartis) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Genoptix, Inc. (Novartis) 2011-2016
Table Genoptix, Inc. (Novartis) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genmark Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genmark Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genmark Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genmark Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and United States Market Share of Genmark Diagnostics 2011-2016
Table Genmark Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genomictree Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genomictree
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomictree 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomictree 2011-2016
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies [...]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new [...]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating [...]
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Global Intrusion Alarm System Market Outlook Report 2017
    Published: 20-Apr-2017        Price: US 2922 Onwards        Pages: 126
    This report studies the Intrusion Alarm System market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Intrusion Alarm System market by product type and applications/end industries. The global Intrusion Alarm System market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022,......
  • United States GPS Watch Tracker Market Report 2017
    Published: 20-Apr-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States GPS Watch Tracker market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growt......
  • Asia-Pacific Object Storage Market Report 2017
    Published: 20-Apr-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the Asia-Pacific Object Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Object Storage for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Ta......
  • Asia-Pacific Optical Encoders Market Report 2017
    Published: 20-Apr-2017        Price: US 4000 Onwards        Pages: 128
    In this report, the Asia-Pacific Optical Encoders market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Optical Encoders for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea ......
  • United States Real Time Clock Market Report 2017
    Published: 20-Apr-2017        Price: US 3800 Onwards        Pages: 111
    In this report, the United States Real Time Clock market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ......
  • 2017-2022 United States Laser Pointer Market Report (Status and Outlook)
    Published: 20-Apr-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Laser Pointer market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as - Quarton - Knorvay - Q......
  • United States Home Cinema Market Report 2017
    Published: 20-Apr-2017        Price: US 3800 Onwards        Pages: 106
    In this report, the United States Home Cinema market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate......
  • Asia-Pacific Power Management Development Boards Market Report 2017
    Published: 20-Apr-2017        Price: US 4000 Onwards        Pages: 129
    In this report, the Asia-Pacific Power Management Development Boards market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Power Management Development Boards for these regions, from 2012 to 2022 (forecast), including - China......
  • EMEA (Europe, Middle East and Africa) LCD Digitizer Market Report 2017
    Published: 20-Apr-2017        Price: US 4000 Onwards        Pages: 112
    In this report, the EMEA LCD Digitizer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of LCD Digitizer for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Mi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs